Global Pet Therapeutic Diet Market Size To Exceed USD 8.12 Billion By 2033: Market Study Report

RELEASE DATE: Jun 2025 Author: Spherical Insights
The Global Pet Therapeutic Diet Market Size is Expected to Grow from USD 3.95 Billion in 2023 to USD 8.12 Billion by 2033, at a CAGR of 7.47% during the forecast period 2023-2033

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

All Weather Tire Market Size Flexible, Printed, and Thin Film Battery Market Size GPU As a Service Market Size IR Camera Market Size

Global Pet Therapeutic Diet Market Size To Exceed USD 8.12 Billion By 2033

According to a research report published by Spherical Insights & Consulting, The Global Pet Therapeutic Diet Market Size is Expected to Grow from USD 3.95 Billion in 2023 to USD 8.12 Billion by 2033, at a CAGR of 7.47% during the forecast period 2023-2033.  

 

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Pet Therapeutic Diet Market Size, Share, and COVID-19 Impact Analysis, By Product (Wet Food and Dry Food), By Animal Type (Dogs, Cats, and Others), By Indication (Renal Care, Obesity Care, Diabetic Care, and Dental Care), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

 

The global pet therapeutic diet market refers to the industry focused on specialized pet food products intended to treat several animal illnesses, particularly those affecting dogs and cats. These diets have been developed to treat conditions including obesity, diabetes, kidney disease, gastrointestinal disorders, allergies, and joint concerns under the supervision of a veterinarian. Key driving factors for the growth of the pet therapeutic diet market include increasing awareness of animal health, growing pet humanization, and an increase in chronic pet diseases. Demand is being prompted by advancements in condition-specific, natural formulations, growing e-commerce, and veterinarian-recommended diets. Preventive care has become emphasized by pet owners, which contributes to growth in both developed and emerging markets. However, limited access to veterinary services, high product costs, and limited understanding in impoverished nations. Furthermore, issues with taste, pet acceptance, and the requirement for expert advice prevent wider market adoption.

 

The dry food segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period.

On the basis of product, the global pet therapeutic diet market is divided into wet food and dry food. Among these, the dry food segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period. The segment growth is attributed to its convenience, cost, and extended shelf life.  Through innovative, condition-specific formulations focusing on chronic illnesses like diabetes and obesity, it encourages improved portion control and maintains consumer preference.

 

The dog segment accounted for the highest revenue share in 2023 and is anticipated to grow at a substantial CAGR during the forecast period.

On the basis of animal type, the global pet therapeutic diet market is divided into dogs, cats, and others. Among these, the dog segment accounted for the highest revenue share in 2023 and is anticipated to grow at a substantial CAGR during the forecast period. The segment growth is driven by the increasing demand for therapeutic remedies as a consequence of pet owners seeing their dogs like members of the family and being prepared to spend extra on special diets to maintain their best condition.

 

The obesity care segment accounted for the largest market share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.

On the basis of indication, the global pet therapeutic diet market is divided into renal care, obesity care, diabetic care, and dental care. Among these, the obesity care segment accounted for the largest market share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment is driven because pet obesity is extremely prevalent and the health threats have become more widely recognized. Weight control is effectively handled by therapeutic diets like Hill's Prescription Diet Metabolic, that drives market expansion.

 

North America is anticipated to hold the largest share of the global pet therapeutic diet market over the predicted timeframe.

North America is anticipated to hold the largest share of the global pet therapeutic diet market over the predicted timeframe. The segment growth can be attributed because pet ownership is high, humanization trends are strong, veterinary infrastructure is outstanding, and pet insurance is readily accessible. Leading companies like Purina, Royal Canin, and Hill's spur innovation, and growing chronic illnesses and a demand for natural, customized diets promote regional market expansion.

 

Asia Pacific is expected to grow at the fastest CAGR in the global pet therapeutic diet market during the forecast period. The segment growth is driven because of increasing veterinary infrastructure, increased disposable incomes, and rising pet humanization. The need for specialized meals is driven by urbanization and rising pet health consciousness. Market expansion across significant countries is further accelerated by the rise of e-commerce and the arrival of regional and international firms.

 

Company Profiling

Major vendors in the global pet therapeutic diet market are Colgate-Palmolive Company (Hill's Pet Nutrition Inc.), Nestlé, Mars Petcare (Royal Canin), General Mills Inc. (Blue Buffalo Company, Ltd.), Diamond Pet Foods, Inc., Virbac, Veterinary Nutrition Group, Farmina Pet Foods, JustFoodForDogs, EmerAid, LLC, and Others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

        

Recent Development

  • In February 2025, Meatly launched "Chick Bites," the world's first lab-grown meat dog treats, in the UK. These treats are made from a combination of plant-based ingredients and lab-grown chicken, produced from a single sample of chicken egg cells. The product aims to provide a sustainable and nutritious option for dogs.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global pet therapeutic diet market based on the below-mentioned segments: 

 

Global Pet Therapeutic Diet Market, By Product

  • Wet Food
  • Dry Food

 

Global Pet Therapeutic Diet Market, ByAnimal Type

  • Dogs
  • Cats
  • Others

 

Global Pet Therapeutic Diet Market, By Indication

  • Renal Care
  • Obesity Care
  • Diabetic Care
  • Dental Care

 

Global Pet Therapeutic Diet Market, Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies